Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Oncol. May 15, 2014; 6(5): 139-144
Published online May 15, 2014. doi: 10.4251/wjgo.v6.i5.139
Published online May 15, 2014. doi: 10.4251/wjgo.v6.i5.139
Factor | Mean SUVmax (95%CI) | Median survival in days (95%CI) |
Sex | ||
Male (n = 191) | 11.4 (10.5, 12.3) | 566 (491, 641) |
Female (n = 80) | 12.1 (10.2, 14.0) | 884 (403, 1364) |
P = 0.950 | P = 0.05 | |
Age in years | ||
Age ≤ 65 (n = 136) | 11.5 (10.5, 12.5) | 575 (456, 694) |
Age > 65 (n = 135) | 11.7 (10.4, 13.1) | 586 (418, 754) |
P = 0.770 | P = 0.25 | |
Histology | ||
Adenocarcinoma (n = 197) | 11.3 (10.2, 12.4) | 570 (483, 657) |
Squamous carcinoma (n = 74) | 12.4 (11.3, 13.6) | 629 (445, 813) |
P = 0.008 | P = 0.75 | |
Tumor location | ||
Upper esophagus (n = 13) | 15.6 (11.4, 19.8) | 973 (142,1804) |
Mid esophagus (n = 50) | 12.8 (11.0, 14.6) | 425 (252, 598) |
Lower esophagus (n = 136) | 10.8 (9.6, 12.0) | 586 (464, 708) |
Junctional (n = 72) | 11.6 (10.0, 13.1) | 684 (430, 938) |
P = 0.010 | P = 0.14 |
- Citation: Al-Taan OS, Eltweri A, Sharpe D, Rodgers PM, Ubhi SS, Bowrey DJ. Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma. World J Gastrointest Oncol 2014; 6(5): 139-144
- URL: https://www.wjgnet.com/1948-5204/full/v6/i5/139.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v6.i5.139